Cargando…
A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma
BACKGROUND: Despite aggressive multimodal therapy, >50% of children with high-risk neuroblastoma (HRNB) relapse. Survival after relapse is rare, and no consensus currently exists on the most effective therapy. OBJECTIVE: To conduct a systematic review of the literature on effectiveness of re-indu...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458963/ https://www.ncbi.nlm.nih.gov/pubmed/30822684 http://dx.doi.org/10.1016/j.ejca.2018.12.032 |